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German. Leaving aside the forward translation and back trans-
lation stages, where the whole text is changed, the grid for each
stage was reviewed, and changes counted. The types of changes
were also considered, to evaluate what each step contributes to
the overall translation process. RESULTS: 1) The reconciliation
stage and second forward translation allowed the investigator to
reconsider their own forward translation and make improve-
ments; 2) the back translation review caught some items where
the translation required improvement; 3) only minor changes
were necessary at developer review stage; 4) harmonisation
allowed tweaks to be made so that all language versions were
conveying the same meanings; 5) very few changes were needed
following pilot testing; and 6) proofreading caught grammatical
and formatting errors. CONCLUSION: As the translations went
through the methodology, improvements to the quality and accu-
racy were made. The forward and back translation processes iron
out problematic wordings. Although in terms of numbers of
changes the developer review and pilot testing appear to have
little effect, these stages serve as an important check of the
previous steps. Without harmonisation, the versions may not
have been so close in meaning. Proofreading is an important step
in removing formatting and grammatical errors that may have
crept in when creating the formatted documents from the grids
used for the translation process.
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OBJECTIVES: To assess the effects of comorbid type 2 diabetes,
high cholesterol or hypertension on work productivity loss
and activity impairment among overweight/obese individuals.
METHODS: The study sample consisted of individuals who
responded to the National Health and Wellness Survey (NHWS)
between March and June of 2006. The NHWS is a nationally
representative, annual, Internet-based survey of non-
institutionalized adults aged 18 and older. It gathers information
regarding respondent demographics, health status, and out-
comes. Overweight/obesity was deﬁned as BMI > 27. Analyses
were conducted on the 19,759 respondents who ﬁt this criterion.
Respondents reported diagnoses of three comorbid conditions:
type 2 diabetes, high cholesterol, hypertension. The Work Pro-
ductivity and Activity Impairment Questionnaire was used to
assess lost productivity and impairment. Linear regression
models were used to determine the independent effects of com-
binations of the three comorbid conditions on productivity loss
and activity impairment. RESULTS: Among obese respondents,
59.35% had at least one of the three speciﬁed comorbid condi-
tions. Individuals with comorbidities were older (diabetes, mean
age 56.9 versus 48.1, p < 0.001) and less likely to be employed
full-time (hypertension 30.9% versus 48.3%, p < 0.001). Signiﬁ-
cant differences were noted between those with and without the
conditions in bivariate analysis. Greater work productivity loss
was observed for those with diabetes (26.0% versus 20.2%,
p < 0.001), high cholesterol (24.1% versus 19.5%, p < 0.001)
or hypertension (24.4% versus 19.2%, p < 0.001). Increased
impairment with daily activities was reported among those with
diabetes (27.1% versus 21.2%, p < 0.001), high cholesterol
(25.7% versus 20.2%, p < 0.001), or hypertension (25.5%
versus 20.2%, p < 0.001). After controlling for confounders, the
presence of all three comorbid conditions was the strongest
correlate of work productivity loss and activity impairment in
multivariate analyses (B = 13.992, p < 0.001 & B = 13.397,
p < 0.001 respectively). CONCLUSION: Overweight\obese indi-
viduals with multiple comorbid conditions reported signiﬁcantly
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OBJECTIVES: To evaluate the safety of antiretroviral therapies
(ART) in decreasing the risk of mother-to-child transmission
(MTCT) of HIV infection. METHODS: Clinical trials of ART
aimed at decreasing the risk of MTCT was systematically iden-
tiﬁed through electronic searches (MEDLINE, EMBASE, BIOSIS,
EBM review, and the Cochrane Library) up until November
2006. Historical search through the reference lists of relevant
articles was also undertaken. For a trial to be included, it had to
be randomized controlled trial of any ART aimed at decreasing
the risk of MTCT and reporting safety data in mothers and/or
infants. The safety was estimated using RR, RD, and NNT
together with 95% conﬁdence intervals. RESULTS: Eleven trials
were included in the meta-analysis. MTCT prophylaxis with
zidovudine monotherapy and the combination with lamivudine
were not associated with congenital abnormality, short-term
hematological, and laboratory toxicities both among pregnant
women and infants. The zidovudine alone or in combination
with lamivudine caused no more adverse events than placebo.
MTCT prophylaxis with nevirapine was not associated with rash
or hepatotoxicity or any serious adverse events among pregnant
women when compared with zidovudine alone or in combination
with lamivudine. CONCLUSION: This systematic review sug-
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OBJECTIVES: To estimate the impact on the National Health
Found budget of infuenza vaccination (Inﬂuvac®) reimburse-
ment in children with malignancies in Poland. METHODS:
Two strategies were compared: inﬂuenza vaccination and
no-vaccination. Population: children with malignancies, <15
years. Proposed vaccination program coverage: 2000 children.
Expected consequences of vaccination on direct medical costs,
related to ﬂu management were assessed and costs of vaccination
in proposed population were calculated. Analysis model was
performed using Polish cost and partly Polish clinical data from
published sources. RESULTS: In proposed population of 2,000
children with malignancies in one year time horizon in Poland
reimbursement costs were 120,000 PLN. Saving due to iﬂuenza
vaccination were 11.75 PLN per oe vaccinated children. Costs
reduction in vaccinated population were mostly dependent on ﬂu
complications incidence and related costs reduction. Expected
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